BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15342961)

  • 1. Toxin-induced tail phosphorylation of hepatocellular S6 kinase: evidence for a dual involvement of the AMP-activated protein kinase in S6 kinase regulation.
    Møller MT; Samari HR; Seglen PO
    Toxicol Sci; 2004 Dec; 82(2):628-37. PubMed ID: 15342961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins.
    Samari HR; Møller MT; Holden L; Asmyhr T; Seglen PO
    Biochem J; 2005 Mar; 386(Pt 2):237-44. PubMed ID: 15461583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the ubiquitin-proteasome proteolysis system by amino acids and insulin involves the adenosine monophosphate-activated protein kinase and mammalian target of rapamycin pathways in rat hepatocytes.
    Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gaudichon C; Tomé D
    Amino Acids; 2011 Jul; 41(2):457-68. PubMed ID: 20957397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
    Williamson DL; Bolster DR; Kimball SR; Jefferson LS
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E80-9. PubMed ID: 16760336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
    Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
    J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes.
    Krause U; Bertrand L; Hue L
    Eur J Biochem; 2002 Aug; 269(15):3751-9. PubMed ID: 12153572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
    Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
    Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Okadaic acid-induced, naringin-sensitive phosphorylation of glycine N-methyltransferase in isolated rat hepatocytes.
    Møller MT; Samari HR; Fengsrud M; Strømhaug PE; øStvold AC; Seglen PO
    Biochem J; 2003 Jul; 373(Pt 2):505-13. PubMed ID: 12697024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside.
    Reiter AK; Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E980-8. PubMed ID: 15613684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
    Du M; Shen QW; Zhu MJ; Ford SP
    J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
    Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
    Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A; Tee AR; Taylor PM; Proud CG
    Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the atypical protein kinase Czeta in regulation of 5'-AMP-activated protein kinase in cardiac and skeletal muscle.
    Ussher JR; Jaswal JS; Wagg CS; Armstrong HE; Lopaschuk DG; Keung W; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E349-57. PubMed ID: 19625676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
    Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K
    Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
    Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
    Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake.
    Stevanovic D; Janjetovic K; Misirkic M; Vucicevic L; Sumarac-Dumanovic M; Micic D; Starcevic V; Trajkovic V
    Neuroendocrinology; 2012; 96(1):24-31. PubMed ID: 22343549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.